Found: 11
Select item for more details and to access through your institution.
Author Correction: Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Author Correction: Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Nek6 knockdown polarized macrophages into a pro‐inflammatory phenotype via inhibiting STAT3 expression.
- Published in:
- International Journal of Experimental Pathology, 2023, v. 104, n. 5, p. 237, doi. 10.1111/iep.12489
- By:
- Publication type:
- Article
Ill‐fitting prosthesis is associated with an increased risk of elevated blood pressures.
- Published in:
- Journal of Oral Rehabilitation, 2024, v. 51, n. 7, p. 1123, doi. 10.1111/joor.13684
- By:
- Publication type:
- Article
Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy.
- Published in:
- Nature Communications, 2016, v. 7, n. 6, p. 11432, doi. 10.1038/ncomms11432
- By:
- Publication type:
- Article
The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling.
- Published in:
- Nature Communications, 2016, v. 7, n. 6, p. 11267, doi. 10.1038/ncomms11267
- By:
- Publication type:
- Article
NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Tumor necrosis factor receptor-associated factor 5 protects against intimal hyperplasia by regulation of macrophage polarization via directly targeting PPARγ.
- Published in:
- Inflammation Research, 2024, v. 73, n. 6, p. 929, doi. 10.1007/s00011-024-01875-8
- By:
- Publication type:
- Article
Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy.
- Published in:
- Journal of Molecular Medicine, 2022, v. 100, n. 12, p. 1721, doi. 10.1007/s00109-022-02269-1
- By:
- Publication type:
- Article
Non-contact assessment of cardiac physiology using FO-MVSS-based ballistocardiography: a promising approach for heart failure evaluation.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-53464-8
- By:
- Publication type:
- Article